Literature DB >> 23588966

[Catheter ablation of paroxysmal atrial fibrillation. Optimal approach and result].

Shibu Mathew1, Andreas Metzner, Feifan Ouyang, Karl-Heinz Kuck, Roland Richard Tilz.   

Abstract

The gold standard in ablation of paroxysmal atrial fibrillation (PAF) is radiofrequency (RF) based point by point pulmonary vein isolation (PVI). In the majority of patients with PAF (80 %) PVI can restore stable SR even during long-term follow-up of up to 5 years. However multiple procedures are often required. Cryo-balloon based PVI is an established technique. Safety and efficacy are comparable to RF ablation. Due to the high success rates in patients with PAF and the progression rate to persistent atrial fibrillation (AF) an early intervention is recommended as implemented in the latest guidelines for AF treatment.

Entities:  

Mesh：

Year:  2013        PMID： 23588966     DOI： 10.1007/s00399-013-0244-z

Source DB:  PubMed          Journal:  Herzschrittmacherther Elektrophysiol        ISSN： 0938-7412


  43 in total

Review 1.  Should atrial fibrillation ablation be considered first-line therapy for some patients? Why atrial fibrillation ablation should be considered first-line therapy for some patients.

Authors:  Atul Verma; Andrea Natale
Journal:  Circulation       Date:  2005-08-23       Impact factor: 29.690

2.  Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy.

Authors:  Cees B De Vos; Günter Breithardt; A John Camm; Paul Dorian; Peter R Kowey; Jean-Yves Le Heuzey; Lisa Naditch-Brûlé; Eric N Prystowsky; Peter J Schwartz; Christian Torp-Pedersen; William S Weintraub; Harry J Crijns
Journal:  Am Heart J       Date:  2012-05       Impact factor: 4.749

3.  Left atrial ablation at the anatomic areas of ganglionated plexi for paroxysmal atrial fibrillation.

Authors:  Evgeny Pokushalov; Alexander Romanov; Sergey Artyomenko; Alex Turov; Natalya Shirokova; Demosthenes G Katritsis
Journal:  Pacing Clin Electrophysiol       Date:  2010-10       Impact factor: 1.976

4.  Prediction of transition to chronic atrial fibrillation in patients with paroxysmal atrial fibrillation.

Authors:  H Sakamoto; M Kurabayashi; R Nagai; J Fujii
Journal:  Circulation       Date:  1998-09-08       Impact factor: 29.690

5.  Electrophysiological breakthroughs from the left atrium to the pulmonary veins.

Authors:  M Haïssaguerre; D C Shah; P Jaïs; M Hocini; T Yamane; I Deisenhofer; M Chauvin; S Garrigue; J Clémenty
Journal:  Circulation       Date:  2000-11-14       Impact factor: 29.690

6.  Regional disparities of endocardial atrial activation in paroxysmal atrial fibrillation.

Authors:  P Jaïs; M Haïssaguerre; D C Shah; S Chouairi; J Clémenty
Journal:  Pacing Clin Electrophysiol       Date:  1996-11       Impact factor: 1.976

7.  Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation.

Authors:  Hakan Oral; Christoph Scharf; Aman Chugh; Burr Hall; Peter Cheung; Eric Good; Srikar Veerareddy; Frank Pelosi; Fred Morady
Journal:  Circulation       Date:  2003-10-13       Impact factor: 29.690

8.  Acute and long-term clinical outcome after endoscopic pulmonary vein isolation: results from the first prospective, multicenter study.

Authors:  Andreas Metzner; Erik Wissner; Boris Schmidt; Julian Chun; Gerhard Hindricks; Christopher Piorkowski; Feifan Ouyang; Karl-Heinz Kuck
Journal:  J Cardiovasc Electrophysiol       Date:  2012-09-11

9.  Small or large isolation areas around the pulmonary veins for the treatment of atrial fibrillation? Results from a prospective randomized study.

Authors:  Thomas Arentz; Reinhold Weber; Gerd Bürkle; Claudia Herrera; Thomas Blum; Jochem Stockinger; Jan Minners; Franz Josef Neumann; Dietrich Kalusche
Journal:  Circulation       Date:  2007-06-11       Impact factor: 29.690

10.  Study design of the man and machine trial: a prospective international controlled noninferiority trial comparing manual with robotic catheter ablation for treatment of atrial fibrillation.

Authors:  Andreas Rillig; Boris Schmidt; Daniel Steven; Udo Meyerfeldt; Luigi DI Biase; Erik Wissner; Rüdiger Becker; Dierk Thomas; Peter Wohlmuth; G Joseph Gallinghouse; Eberhardt Scholz; Werner Jung; Stefan Willems; Andrea Natale; Feifan Ouyang; Karl Heinz Kuck; Roland Tilz
Journal:  J Cardiovasc Electrophysiol       Date:  2012-11-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.